Market report includes a comprehensive understanding of current treatment practices, emerging HER2+ gastric cancer therapies, market share of individual therapies, and current and forecasted HER2+ ...

Pāpāmoa retiree Marion Henriksen was meant to be travelling in Germany and Austria with a friend. Instead, she had to cancel ...

Job opportunities at the Port of Los Angeles are dwindling as President Trump's steep tariffs take a hit on global trade and a major economic engine for the regional economy.

Just in time for peak travel season, Terminix®, a Rentokil Terminix company, announced today its annual list of the Top 50 Most Bed Bug-Infested U.S. Cities, based on 2024 service data from more than ...

Solventum, a global MedTech leader at the forefront of infection prevention innovation, today announced the launch of its Attesttm Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack.

The Phase III DESTINY-Breast09 clinical trial has delivered groundbreaking results, demonstrating that ENHERTU® ...

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

A slow ascent for more than two decades has given way to a sharp rise in important ADC readouts, marking a milestone era for targeted treatments.

As the buzz increases in volume and the clock to kick-off counts down, keep an eye on this Spotlight On page for content ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.